Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
HIV-1-specific cytotoxic T lymphocytes and the control of HIV-1 replication.
Jassoy C, Walker BD. Jassoy C, et al. Springer Semin Immunopathol. 1997;18(3):341-54. doi: 10.1007/BF00813502. Springer Semin Immunopathol. 1997. PMID: 9089953 Review. No abstract available.
Hepatitis C virus (HCV)-specific memory B-cell responses in transiently and chronically infected HIV positive individuals.
Reiche S, Nestler C, Sieg M, Schulz K, Cordes C, Krznaric I, Jassoy C. Reiche S, et al. Among authors: jassoy c. J Clin Virol. 2014 Apr;59(4):218-22. doi: 10.1016/j.jcv.2014.01.023. Epub 2014 Feb 4. J Clin Virol. 2014. PMID: 24566009
BACKGROUND: Antibody responses to hepatitis C virus (HCV) occur delayed and overly decline after viral clearance indicating that the B-cell response to HCV is abnormal. ...
BACKGROUND: Antibody responses to hepatitis C virus (HCV) occur delayed and overly decline after viral clearance indicating that the …
Induction of humoral and cellular immune responses in mice by HIV-derived infectious pseudovirions.
Racek T, Jármy G, Jassoy C. Racek T, et al. Among authors: jassoy c. AIDS Res Hum Retroviruses. 2006 Nov;22(11):1162-6. doi: 10.1089/aid.2006.22.1162. AIDS Res Hum Retroviruses. 2006. PMID: 17147504
BALB/c mice were immunized in a DNA prime pseudovirion boost fashion. Immunization induced a Gag-specific antibody response, high titers of neutralizing antibodies directed against the VSV-G protein and a Gag-specific IFN-gamma-secreting cytotoxic T lymphocyte (CTL) respon …
BALB/c mice were immunized in a DNA prime pseudovirion boost fashion. Immunization induced a Gag-specific antibody response, high tit …
Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs.
Scheller C, Sopper S, Koutsilieri E, Ludwig S, Ter Meulen V, Jassoy C. Scheller C, et al. Among authors: jassoy c. Ann N Y Acad Sci. 2003 Dec;1010:209-12. doi: 10.1196/annals.1299.036. Ann N Y Acad Sci. 2003. PMID: 15033722
Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.
Bussmann BM, Reiche S, Bieniek B, Krznaric I, Ackermann F, Jassoy C. Bussmann BM, et al. Among authors: jassoy c. Virology. 2010 Feb 5;397(1):7-13. doi: 10.1016/j.virol.2009.11.003. Epub 2009 Dec 4. Virology. 2010. PMID: 19962720
Evaluation of drug resistance in HIV infection.
Weissbrich B, Heinkelein M, Jassoy C. Weissbrich B, et al. Among authors: jassoy c. Adv Virus Res. 2002;58:157-202. doi: 10.1016/s0065-3527(02)58005-2. Adv Virus Res. 2002. PMID: 12205779 Review. No abstract available.
Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95.
Scheller C, Sopper S, Chen P, Flory E, Koutsilieri E, Racek T, Ludwig S, ter Meulen V, Jassoy C. Scheller C, et al. Among authors: jassoy c. J Biol Chem. 2002 May 3;277(18):15459-64. doi: 10.1074/jbc.M200763200. Epub 2002 Feb 19. J Biol Chem. 2002. PMID: 11854296
Human immunodeficiency virus glycoprotein-specific CD4+ cytotoxic T lymphocytes are involved in two types of cytotoxicity: antigen-specific and cell-cell fusion-related cell lysis.
Ehret R, Heinkelein M, Siliciano RF, Jassoy C. Ehret R, et al. Among authors: jassoy c. AIDS Res Hum Retroviruses. 1997 Aug 10;13(12):1017-21. doi: 10.1089/aid.1997.13.1017. AIDS Res Hum Retroviruses. 1997. PMID: 9264288
61 results
Jump to page
Feedback